Found: 15
Select item for more details and to access through your institution.
Therapeutic Interaction of Apatinib and Chidamide in T-cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 10, p. 977, doi. 10.3390/jpm11100977
- By:
- Publication type:
- Article
Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0377-8
- By:
- Publication type:
- Article
Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 3839, doi. 10.1007/s00277-024-05683-2
- By:
- Publication type:
- Article
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.780118
- By:
- Publication type:
- Article
CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.618908
- By:
- Publication type:
- Article
Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 9, p. 1, doi. 10.1038/s41419-020-02972-2
- By:
- Publication type:
- Article
Low‐dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 9, p. 1076, doi. 10.1002/mc.23238
- By:
- Publication type:
- Article
Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0310-1
- By:
- Publication type:
- Article
The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00282-1
- By:
- Publication type:
- Article
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China.
- Published in:
- 2021
- By:
- Publication type:
- Letter
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.
- Published in:
- 2020
- By:
- Publication type:
- Letter
The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45721-z
- By:
- Publication type:
- Article